# Coixol ameliorates dopaminergic neurodegeneration by inhibiting neuroinflammation and protecting mitochondrial function

**Authors:** Shuo Yang, Jiaxi Han, Miao Xue, Yiming Zhang, Aohan Yan, Xiyu Gao, Jiangmei He, Xiaojia Sun, Shoupeng Fu, Dianfeng Liu, Bingxu Huang

PMC · DOI: 10.3389/fphar.2025.1657910 · Frontiers in Pharmacology · 2025-10-02

## TL;DR

Coixol, a compound from a plant, helps reduce brain inflammation and protect mitochondria in a mouse model of Parkinson's disease.

## Contribution

This study is the first to demonstrate that coixol alleviates Parkinson's disease symptoms by targeting neuroinflammation and mitochondrial function.

## Key findings

- Coixol improves motor dysfunction and neuronal damage in PD mice by inhibiting neuroinflammation.
- Coixol suppresses NF-κB and MAPK pathways and regulates the NLRP3 inflammasome to reduce inflammation.
- Coixol protects mitochondrial function by reducing ROS-induced damage in Parkinson's disease models.

## Abstract

Extensive research has revealed that neuroinflammation plays an important role in Parkinson’s disease (PD). Coixol, extracted from Coix lacryma-jobi L., exhibits anti-inflammatory and antioxidant effects in various diseases. However, the effect of coixol on PD remains unclear. The aim of this study is to investigate the effects of coixol in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model. Our results show that coixol improves the motor dysfunction and neuronal damage in PD mice by inhibiting neuroinflammation and maintaining mitochondrial function. Moreover, coixol suppressed the overactivation of the nuclear transcription factor κB (NF-κB) and the mitogen-activated protein kinase (MAPK) signaling pathways and regulated the NLR family pyrin structural domain 3 (NLRP3)/cysteinyl aspartate-specific proteinase-1 (Caspase1)/interleukin-1β (IL-1β) signaling pathway to inhibit neuroinflammation in PD mice. The results show that coixol mitigated reactive oxygen species (ROS)-induced mitochondrial damage, thereby inhibiting the overactivation of the NLRP3 inflammasome. Taken together, we found that coixol alleviates dopaminergic neurodegeneration in PD mice by inhibiting the activation of NF-κB and MAPK signaling pathways to suppress neuroinflammation and protect mitochondrial function from ROS production to regulate NLRP3 inflammasome activation.

## Linked entities

- **Genes:** NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548], Caspase1 (caspase-1) [NCBI Gene 692604], IL1B (interleukin 1 beta) [NCBI Gene 3553], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], MAPK (mitogen activated kinase-like protein) [NCBI Gene 7446652]
- **Chemicals:** Coixol (PubChem CID 10772), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (PubChem CID 1388)
- **Diseases:** Parkinson’s disease (MONDO:0005180)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}
- **Diseases:** neuroinflammation (MESH:D000090862), motor dysfunction (MESH:D000068079), inflammatory (MESH:D007249), mitochondrial damage (MESH:D028361), neurodegeneration (MESH:D019636), PD (MESH:D010300), neuronal damage (MESH:D009410)
- **Chemicals:** Coixol (MESH:C031896), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MESH:D015632), ROS (MESH:D017382)
- **Species:** Coix lacryma-jobi (Job's tears, species) [taxon 4505], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12528104/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12528104/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12528104/full.md

---
Source: https://tomesphere.com/paper/PMC12528104